Hormone Health and Endocrine Care

In Woodhouse-Sakati syndrome (WSS), the endocrine system—the body’s network of hormone-producing glands—is almost always affected. Because the DCAF17 pathogenic variants impact the pituitary gland and other organs, most individuals will need ongoing care from an endocrinologist to manage hormones for growth, puberty, and blood sugar ^[1][2].

Managing Puberty and Hypogonadism

The most common endocrine feature of WSS is hypogonadism, which is reported in a large majority of cases ^[1]. This means the body does not produce enough sex hormones to trigger the changes of puberty naturally.

• Sex-Steroid Replacement: Because puberty does not usually start on its own in WSS, doctors use individualized sex-steroid replacement (like estrogen or testosterone) to support development ^[3][4].
• Personalized Timing: The timing for starting this therapy is not the same for everyone. Your medical team will tailor the start date and dosage based on growth potential, bone age, and patient/family readiness through shared decision-making ^[3][5].
• Long-Term Health: Beyond physical appearance, these hormones are vital for building strong bones, supporting sexual health, and preventing osteoporosis (weak, brittle bones) later in life ^[3]. Fertility counseling may also be part of this process.

Understanding WSS-Related Diabetes

Diabetes mellitus often develops in adolescence or early adulthood (affecting roughly 46% of patients in one 58-person cohort) ^[1].

• Insulinopenic Nature: In WSS, the diabetes is often insulinopenic, meaning the pancreas simply does not produce enough insulin ^[6][7]. It is usually non-autoimmune ^[6].
• Treatment Decisions: Because it is often insulin-deficient, the appropriate treatment may be insulin right from the time of diagnosis. Treatment is determined by your diabetes team based on glucose levels, ketones, C-peptide, and antibodies, not just the WSS label ^[8][6].
• Sick-Day Management: Work with your diabetes team to create a “sick-day plan.” You must know exactly how to adjust medications, when to test for ketones, and who to call for high readings, vomiting, or a missed insulin dose during an illness.

Thyroid and Growth Hormone Concerns

The “master gland” (pituitary) issues in WSS can affect other hormones as well:

• Hypothyroidism: An underactive thyroid has been observed in subgroups of WSS patients ^[1]. This can be “primary” (a problem with the thyroid itself) or “secondary” (a problem with the pituitary gland’s signal) ^[6][8]. Suspected central hypothyroidism requires an endocrinologist to interpret Free T4 and TSH levels, and is managed with levothyroxine—a medication completely separate from sex-steroid replacement.
• Growth Hormone (GH) Concerns: Some children with WSS are shorter than expected for their age. Research in selected subgroups has shown that some WSS patients have a Growth Hormone deficiency when formally tested ^[9][10].
• Treatment: Growth is assessed on serial charts and through formal endocrine testing. For those who qualify, treatment with recombinant human Growth Hormone is considered, though eligibility and benefits are individualized ^[11][5].

A Lifetime of Surveillance

Because these hormone issues can emerge at different ages, endocrine health is a lifelong focus. Standard surveillance typically includes individualized, periodic testing of blood sugar, thyroid function, and pubertal development ^[8][12].